Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Examining Tear Film Dynamics Using High Resolution Spectroscopy
Author Affiliations & Notes
  • Simran Mangwani Mordani
    Cornea and External Diseases, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Department of Ophthalmology, VA Miami Healthcare System, Miami, Florida, United States
  • Kelly Ann Acuña
    Cornea and External Diseases, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Department of Ophthalmology, VA Miami Healthcare System, Miami, Florida, United States
  • Anat Galor
    Cornea and External Diseases, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Department of Ophthalmology, VA Miami Healthcare System, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Simran Mangwani Mordani None; Kelly Acuña None; Anat Galor Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&D (CSRD) I01 CX002015 (Dr. Galor), Biomedical Laboratory R&D (BLRD) Service I01 BX004893 (Dr. Galor), Rehabilitation R&D (RRD) I21 RX003883 (Dr. Galor), Department of Defense Gulf War Illness Research Program (GWIRP) W81XWH-20-1-0579 (Dr. Galor) and Vision Research Program (VRP) W81XWH-20-1-0820 (Dr. Galor), National Eye Institute U01 EY034686 (Dr. Galor), R01EY026174 (Dr. Galor), R61EY032468 (Dr. Galor), U01EY034686 (Dr. Galor), NIH Center Core Grant P30EY014801 (institutional) and Research to Prevent Blindness Unrestricted Grant GR004596-1 (institutional)., Code F (Financial Support)
  • Footnotes
    Support  Supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&D (CSRD) I01 CX002015 (Dr. Galor), Biomedical Laboratory R&D (BLRD) Service I01 BX004893 (Dr. Galor), Rehabilitation R&D (RRD) I21 RX003883 (Dr. Galor), Department of Defense Gulf War Illness Research Program (GWIRP) W81XWH-20-1-0579 (Dr. Galor) and Vision Research Program (VRP) W81XWH-20-1-0820 (Dr. Galor), National Eye Institute U01 EY034686 (Dr. Galor), R01EY026174 (Dr. Galor), R61EY032468 (Dr. Galor), U01EY034686 (Dr. Galor), NIH Center Core Grant P30EY014801 (institutional) and Research to Prevent Blindness Unrestricted Grant GR004596-1 (institutional).
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4033. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Simran Mangwani Mordani, Kelly Ann Acuña, Anat Galor; Examining Tear Film Dynamics Using High Resolution Spectroscopy. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4033.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dry eye (DE) is an umbrella term that encompasses a wide range of signs. Currently available tests do not capture all aspects of tear film status thus, novel instruments are needed. We examined tear film dynamics with Tear Film Imager (TFI, AdOM, Israel), a machine that measures lipid, muco-aqueous level thicknesses and dynamics over time with nanometric resolution. We report ranges and stability of these novel metrics and their correlation with traditional DE diagnostic tests.

Methods : Retrospective study of 34 individuals who underwent an ocular surface assessment and TFI imaging. Participants were grouped based on tear function as 1) healthy (tear break-up time, TBUT>10s, Schirmer, Sch>10mm, n=15); 2) evaporative (TBUT<10s, Sch>10mm, n=8); 3) aqueous deficient (TBUT>10s, Sch<10mm, n=6); and 4) mixed (TBUT<10s, Sch<10mm, n=5). Individuals had up to 3 scanning sessions of the right eye, two at baseline and one ~1 week later. High-quality scans were selected. Tear film metrics included: mucous-aqueous layer thickness (MALT), mucous-aqueous thinning rate (MALTR), lipid layer thickness (LLT), lipid break-up time (LBUT), lipid map uniformity (LMU) and inter-blink interval (IBI).

Results : Mean age was 31±9.1 years, 79% self-identified as White, 59% as female, and 53% as Hispanic. A total of 65 scans were found to be of high quality. Median MALT for the first high quality scan for each participant was lowest in the mixed DE group (2518nm, 1561–4263nm) compared to the other groups (healthy: 2933nm, 1624–4817nm; evaporative 3882nm, 2404–5156nm; aqueous: 3178nm, 2023–4855nm). Median LLT was also lowest in the mixed group (37.6nm, 11.9–76.8nm vs. healthy: 53.8nm, 11.1–137.5nm; evaporative 38.3nm, 15.5–117.1nm; aqueous: 50.4nm, 35.3 – 127.2nm). Overall, heterogeneity was noted with respect to all TFI measures within and across groups. Paired t-tests comparisons of TFI scans taken on the same (n=13) and repeat visit (n=18) showed no statistically significant changes in any parameters. MALT was not significantly correlated with Schirmer (r=0.24, n=31), LLT was related to TBUT (r=0.35, p=0.05, n=33).

Conclusions : TFI can quantify aqueous and lipid layer tear metrics that cannot be assessed with current testing. TFI measurements may offer an objective way to reclassify ocular surface diseases but further studies in this regard are needed.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×